Financials MOA Life Plus Co. Ltd.

Equities

A142760

KR7142760008

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-05-13 EDT 5-day change 1st Jan Change
2,340 KRW +2.86% Intraday chart for MOA Life Plus Co. Ltd. -11.36% +9.86%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 197,110 124,311 172,971 239,297 112,271 68,746
Enterprise Value (EV) 1 223,685 145,168 204,069 232,510 132,911 56,129
P/E ratio -11.4 x -4.33 x -6.16 x -10.6 x -4.45 x 8.55 x
Yield - - - - - -
Capitalization / Revenue 2.29 x 1.71 x 2.15 x 2.37 x 1.12 x 3.77 x
EV / Revenue 2.6 x 1.99 x 2.54 x 2.3 x 1.32 x 3.08 x
EV / EBITDA -163 x -11.1 x -33.6 x -29.6 x -16.9 x 54.5 x
EV / FCF -11.4 x -7.76 x -5.9 x -38.2 x -15.9 x 4.25 x
FCF Yield -8.77% -12.9% -16.9% -2.62% -6.3% 23.5%
Price to Book 8.39 x 5.22 x 5.65 x 5.42 x 5.25 x 2.08 x
Nbr of stocks (in thousands) 15,960 17,683 27,412 28,658 31,449 32,275
Reference price 2 12,350 7,030 6,310 8,350 3,570 2,130
Announcement Date 3/15/19 3/18/20 3/19/21 3/23/22 3/23/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 86,067 72,877 80,453 101,170 100,413 18,245
EBITDA 1 -1,370 -13,113 -6,065 -7,850 -7,857 1,031
EBIT 1 -5,557 -18,075 -11,958 -14,651 -14,591 -5,164
Operating Margin -6.46% -24.8% -14.86% -14.48% -14.53% -28.3%
Earnings before Tax (EBT) 1 -16,542 -41,308 -31,691 -36,736 -34,990 -6,139
Net income 1 -17,228 -28,046 -21,138 -19,768 -23,137 8,009
Net margin -20.02% -38.48% -26.27% -19.54% -23.04% 43.9%
EPS 2 -1,081 -1,622 -1,024 -790.2 -802.1 249.0
Free Cash Flow 1 -19,607 -18,713 -34,587 -6,094 -8,373 13,211
FCF margin -22.78% -25.68% -42.99% -6.02% -8.34% 72.41%
FCF Conversion (EBITDA) - - - - - 1,281.98%
FCF Conversion (Net income) - - - - - 164.96%
Dividend per Share - - - - - -
Announcement Date 3/15/19 3/18/20 3/19/21 3/23/22 3/23/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 26,575 20,857 31,098 - 20,639 -
Net Cash position 1 - - - 6,787 - 12,617
Leverage (Debt/EBITDA) -19.4 x -1.591 x -5.128 x - -2.627 x -
Free Cash Flow 1 -19,607 -18,713 -34,587 -6,094 -8,373 13,211
ROE (net income / shareholders' equity) -31.3% -65.3% -44% -37.3% -40.7% -11.9%
ROA (Net income/ Total Assets) -3.64% -7.5% -4.41% -4.83% -5.41% -3.27%
Assets 1 473,371 374,134 479,129 409,666 427,858 -245,040
Book Value Per Share 2 1,472 1,347 1,116 1,541 680.0 1,022
Cash Flow per Share 2 2,400 2,459 1,395 2,063 386.0 587.0
Capex 1 4,061 23,502 17,783 1,767 1,717 339
Capex / Sales 4.72% 32.25% 22.1% 1.75% 1.71% 1.86%
Announcement Date 3/15/19 3/18/20 3/19/21 3/23/22 3/23/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A142760 Stock
  4. Financials MOA Life Plus Co. Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW